---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-022886"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2026-05-14T12:30:25+00:00"
generated_at: "2026-05-14T12:36:53.077535+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
confidence: "medium"
source: SEC EDGAR
---

# Microbot Medical records first revenue from LIBERTY; Q2 revenue already exceeds Q1

## Summary
- Recorded revenue from limited market release of LIBERTY System in Q1 2026; transitioned to full market release in Q2.
- Q2 revenue mid-way through quarter already exceeds total Q1 revenue; accounts more than doubled since LMR ended.
- Hospitals in six states (GA, FL, NY, MI, MA, NC) have adopted the system; Boston now has multiple accounts.
- First robotic procedures include PAE for BPH, GAE for knee pain, and Y-90 radioembolization for liver cancer.
- Growth supported by updated occupational radiation guidelines from nine medical societies including AMA.

## SEC filing metadata
- accession: 0001493152-26-022886
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2026-05-14T12:30:25+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- confidence: medium
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315226022886/0001493152-26-022886-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315226022886/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-022886
- JSON: https://secwatch.observer/filing/0001493152-26-022886.json
- Plain text: https://secwatch.observer/filing/0001493152-26-022886.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.